Stay updated on Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page.

Latest updates to the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page
- Check4 days agoChange DetectedA banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check11 days agoChange DetectedThe revision number in the footer changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the trial details, with added HTML indicating a 403 state. This means the NCT03785925 record is currently inaccessible on ClinicalTrials.gov.SummaryDifference18%

- Check60 days agoChange DetectedAdded NIH grant/contract attribution for 2018 and updated the site revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4. This is a metadata/version update and does not alter the displayed study information.SummaryDifference0.0%

Stay in the know with updates to Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page.